Steven B. Ratoff
DirectorMr. Steven B. Ratoff, C.P.A., has been the Chief Executive Officer and President at Novadel Pharma Inc. since January 1, 2010. Mr. Steven B. Ratoff served as Interim Chief Financial Officer of Eagle Pharmaceuticals Inc. since March 8, 2024 until November 11, 2024 and served as its Principal Finance and accounting Officer since March 2024 until November 11, 2024. Mr. Ratoff has been Corporate Secretary and Interim Chief Financial Officer of Novadel Pharma Inc. since July 31, 2011. He served as a Corporate Secretary and Interim Chief Financial Officer of Novadel Pharma Inc. from April 30, 2009 to June 16, 2010. He served as an Interim Chief Executive Officer and President of Novadel Pharma Inc. from July 23, 2007 to January 1, 2010. He served as Venture Partner of ProQuest Investments, a biopharmaceutical venture capital firm since December 2004. He is a seasoned executive with extensive experience in the global pharmaceutical and consumer products industries. Mr. Ratoff began his career at Arthur Anderson and Co. where he worked from 1965 to 1975. He served as the President and Chief Executive Officer of ProQuest Investments and Bristol-Myers Squibb Co. He served as an Interim Chief Executive Officer of Cima Labs Inc. from May 1, 2003 to August 2004. He served as the President and Chief Executive Officer of Protherics Salt Lake City Inc. (a/k/a MacroMed Inc.) from February 2001 to December 2001. From December 1994 to February 2001, Mr. Ratoff served as an Executive Vice President and Chief Financial Officer of Brown-Forman Corporation. From February 1992 to November 1994, he served as an Investor in a number of small privately held companies. He served as a Senior Vice President, Executive Vice President and Chief Financial Officer of the Pharmaceutical Group of Bristol-Myers Squibb Co. from January 1990 to January 1992 and held several positions at Bristol-Meyers since joining in 1975. Mr. Ratoff has been the Chairman of Novadel Pharma Inc. since September 15, 2006. He served as the Non-Executive Chairman of Axonyx Inc. since September 14, 2005. He served as the Chairman of Cima Labs Inc. since March 11, 2003. Mr. Ratoff served as the Chairman of the Board of TorreyPines Therapeutics Inc. from September 2005 to October 2006. He has been a Director of Eagle Pharmaceuticals Inc. since March 2007. He serves as a Director of Doctations Inc. Mr. Ratoff has been a Director of Novadel Pharma Inc. since January 17, 2006 and Protherics Salt Lake City, Inc. since 1998. He served as a Member of Advisory Board at Progressive Brands, Inc. He served as a Director of TorreyPines Therapeutics Inc. since May 2005 and Raptor Pharmaceuticals Corp. until June 12, 2009. He served as a Director of InKine Pharmaceutical Co. Inc. from February 1998 to September 2005. He served as a Non-Executive Director of Axonyx Inc. since May 5, 2005 and Cima Labs Inc. since March 1995. He was a Certified Public Accountant. Mr. Ratoff holds a B. S. in Business Administration from Boston University in 1964 and an MBA with Distinction from the University of Michigan in 1965.
Positions
- Company NameEagle Pharmaceuticals, Inc.Stock CodeEGRXPositionDirectorColleagues
- MGMichael GravesCEO & Chairman
- CSChristopher Stanley KrawtschukCFO and Principal Financial & Accounting Officer
- DODaniel O'ConnorExecutive VP, Chief Strategy Officer & Head of Corporate Development
- VRValentin R. CurtSenior Vice President of Clinical Drug Development
- RLRobert L. GlenningIndependent Director
- RARichard A. EdlinIndependent Director
- JKJennifer K. SimpsonLead Independent Director
